EPO and Miyoshi myopathy: The MM associated IgG2b and kappa light chain serum levels which increased considerably following injection of the MM cells36 (Fig. 1), were significantly decreased in MM mice that were treated with EPO, while the non-pathological lambda light chain levels and IgA, remained unchanged (Fig. 1a–d and, Figure S2, respectively).